ARBOR VITA CORPORATION

Basic Information

6611 Dumbarton Circle
FREMONT, CA, -

Company Profile

n/a

Additional Details

Field Value
DUNS: 37387904
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N
Number of Employees: n/a


  1. Commercialization of the OncoE6TM Cervical Test for detection of HPV induced mali

    Amount: $961,000.00

    DESCRIPTION (provided by applicant): Commercialization of the OncoE6TM Cervical Test for detection of HPV induced malignancy Cervical cancer is a major cause of the cancer-related mortality of women a ...

    SBIR Phase II 2013 Department of Health and Human Services
  2. Development of an HPV-E6 Cervical Neoplasia Test for Use in Centralized Diagnosti

    Amount: $296,989.00

    DESCRIPTION (provided by applicant): Cervical cancer is the leading cause of cancer-related death in women. It causes over 250,000 death world-wide / year, with 80% occurring in countries without sys ...

    SBIR Phase I 2012 Department of Health and Human Services
  3. PDZ-targeted Therapeutics for Cervical Cancer

    Amount: $208,622.00

    DESCRIPTION (provided by applicant): Oncogenic variants of human papilloma virus (HPV) have been correlated with cervical cancer at a frequency of gt 99%, and also cause penile, anal and head and nec ...

    SBIR Phase I 2010 Department of Health and Human Services
  4. E6 Oncoprotein Based Rapid Test for Anal Neoplasia

    Amount: $692,354.00

    DESCRIPTION (provided by applicant): The prevalence of anal pre-cancer and cancer have substantially increased during the past decades. This is especially true for HIV-positive men and women, and for ...

    SBIR Phase I 2010 Department of Health and Human Services
  5. Development of an E6 based Rapid Strip Test Commercial Prototype for Cervical Can

    Amount: $2,000,000.00

    DESCRIPTION (provided by applicant): Cervical cancer is a global health problem that continues to result in over 250,000 deaths a year, with 80% occurring in developing countries. Early detection of c ...

    SBIR Phase II 2009 Department of Health and Human Services
  6. Translation of a Novel Stroke Drug Administration

    Amount: $1,543,800.00

    DESCRIPTION (provided by applicant): Stroke is a major cause of morbidity in the United States, affecting over 600,000 people annually. The only therapeutics currently available for the treatment of s ...

    SBIR Phase II 2009 Department of Health and Human Services
  7. A Novel Diagnostic Assay for Oncogenic Human Papillomaviruses

    Amount: $875,698.00

    DESCRIPTION (provided by applicant): Arbor Vita Corporation (AVC) has developed a novel cervical cancer diagnostic based on an understanding of the biology of human papillomavirus (HPV). HPV infection ...

    SBIR Phase II 2006 Department of Health and Human Services
  8. Rapid Strip Test for Cervical Cancer via HPV-E6 Detection

    Amount: $597,497.00

    DESCRIPTION (provided by applicant): Cervical cancer is a global health problem that continues to result in over 200,000 deaths a year and has one of the worst survival rates following diagnosis. Earl ...

    SBIR Phase I 2006 Department of Health and Human Services
  9. A Novel Drug To Reduce Neronal Damage Following Stroke

    Amount: $197,624.00

    DESCRIPTION (PROVIDED BY APPLICANT): Arbor Vita proposes to determine the selectivity profiles of NMDA Receptors for PDZ domains and to identify selective inhibitors for use in reducing neuronal damag ...

    SBIR Phase I 2005 Department of Health and Human Services
  10. Prevention and Treatment of Cervical Cancer

    Amount: $200,186.00

    DESCRIPTION (provided by applicant): Arbor Vita proposes to validate the interactions of oncogenic E6 variants with a specific cellular protein family as a target for therapeutic intervention in Human ...

    SBIR Phase I 2003 Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government